Table 2 Contingency table for the descriptive analysis of the two study groups.
Without checklist | With checklist | p-valor | ||||
|---|---|---|---|---|---|---|
n | % | n | % | |||
Origin | Alicante | 30 | 66,7% | 31 | 68,9% | 0,822 |
Valencia | 15 | 33,3% | 14 | 31,1% | ||
Sex | Female | 16 | 35,6% | 10 | 22,2% | 0,163 |
Male | 29 | 64,4% | 35 | 77,8% | ||
Stage at Diagnosis | 1 | 7 | 15,6% | 4 | 8,9% | 0,563 |
2 | 3 | 6,7% | 2 | 4,4% | ||
3 | 11 | 24,4% | 8 | 17,8% | ||
4 | 0 | 0,0% | 3 | 6,7% | ||
4a | 14 | 31,1% | 17 | 37,8% | ||
4b | 7 | 15,6% | 8 | 17,8% | ||
4c | 3 | 6,7% | 3 | 6,7% | ||
Metastasis | 0 (No metastasis) | 42 | 93,3% | 42 | 93,3% | 1,000 |
1(Metastasis) | 3 | 6,7% | 3 | 6,7% | ||
HPV | Negative/Undetermined | 32 | 71,1% | 35 | 77,8% | 0,468 |
Positive | 13 | 28,9% | 10 | 22,2% | ||
Age | Media (SD) | 59,4 | (10,3) | 62,3 | (9,5) | 0,179 |
